Search This Blog

Thursday, November 7, 2019

Pacira Pharmaceuticals EPS beats by $0.16, misses on revenue

Pacira Pharmaceuticals (NASDAQ:PCRX): Q3 Non-GAAP EPS of $0.48 beats by $0.16; GAAP EPS of -$0.15 misses by $0.20.
Revenue of $104.7M (+25.5% Y/Y) misses by $0.18M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)